Hypoglycemic agent 4

Hypoglycemic agent 4 (Compound 5b) is an orally active tetrahydroacridine derivative with blood sugar-lowering properties. It demonstrates strong binding affinity to critical diabetes targets: DPP-IV, SGLT1, and GLUT2. Hypoglycemic agent 4 effectively inhibits glucose diffusion and reduces fasting blood glucose levels in Streptozotocin-induced diabetic rats, comparable to Gliclazide. It is applicable in type 2 diabetes research.